Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 3Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Recruiting 2Completed 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 1Gynecologic 1Classical hematology 1Breast 1

Conditions

Breast Neoplasms 2760Carcinoma, Non-Small-Cell Lung 2260Prostatic Neoplasms 1425Colorectal Neoplasms 1290Neoplasms 1258Multiple Myeloma 1084Lung Neoplasms 1048Neoplasm Metastasis 994Leukemia, Myeloid, Acute 984Lymphoma 900Melanoma 862Pancreatic Neoplasms 818Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 753Recurrence 750Leukemia 733Lymphoma, Non-Hodgkin 684Leukemia, Lymphocytic, Chronic, B-Cell 665Lymphoma, Large B-Cell, Diffuse 616Squamous Cell Carcinoma of Head and Neck 615Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 596Brain Neoplasms 592Carcinoma, Renal Cell 586Glioblastoma 572Rectal Neoplasms 563Myelodysplastic Syndromes 522Sarcoma 521Lymphoma, Follicular 516

Interventions

Interleukin-7 2angiotensin I (1-7) 1Thymalfasin 1Sodium Chloride 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Lymphopenia × Clear all
NCT07258160 2026-01-09

Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors

Second Affiliated Hospital of Soochow University

Phase 2 Recruiting
127 enrolled

Lymphopenia

NCT07267234 2025-12-05

PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)

Second Affiliated Hospital of Soochow University

Phase 2 Not yet recruiting
65 enrolled

Lymphopenia

NCT06584006 2024-09-19

Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting
50 enrolled
Other hematologic neoplasm

Lymphopenia, Hematologic Neoplasms

NCT04426201 2024-04-11

ILIAD-7-US-O

Revimmune

Phase 2 Terminated
10 enrolled

COVID-19, Lymphopenia

NCT00771810 2017-11-13

Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

Tarix Pharmaceuticals

Phase 2 Completed
34 enrolled 19 charts
Classical hematologyGynecologic

Cytopenia, Anemia, Lymphopenia, Neutropenia, Ovarian Neoplasms, Thrombocytopenia

NCT01368107 2015-02-09

Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients

Centre Leon Berard

Phase 2 Completed
24 enrolled
Breast

Breast Neoplasms, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡